Huntsman Ronald Kirk 4
4 · Vivos Therapeutics, Inc. · Filed Dec 23, 2020
Insider Transaction Report
Form 4
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2020-12-23$7.27/sh+1,000$7,267→ 1,500 total
Holdings
- 333,334
Stock Option
Exercise: $1.65Exp: 2022-09-30→ Common Stock (333,334 underlying) - 1,749,000(indirect: See Note)
Common Stock
Footnotes (3)
- [F1]1,000 shares purchased in prices ranging from $7.25 through $7.2798 per share.
- [F2]Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
- [F3]The option is fully vested and exercisable.